SI-BONE, Inc. (SIBN): R&D Expense
$17.45M
Year ended 2025-12-31
$18.02M
Trailing 12 months to 2026-06-30
+8.6%
3-year compound annual growth
+13.0%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.45M | +5.4% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $16.56M | +10.2% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $15.03M | +10.3% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $13.63M | +9.5% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $12.44M | +31.5% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $9.46M | +29.9% | 2022-03-01, From 2020-01-01 |
| 2019-12-31 | $7.28M | +35.4% | 2021-03-10, From 2019-01-01 |
| 2018-12-31 | $5.38M | -2.5% | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $5.51M | n/a | 2019-03-14, From 2017-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $17.45M | +5.4% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $20.28M | -1.5% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $64.92M | +49.2% |
| Cerus Corp (CERS) | 2025-12-31 | $67.72M | +15.0% |
| Orthopediatrics Corp (KIDS) | 2025-12-31 | $9.10M | -17.5% |
| Lemaitre Vascular Inc (LMAT) | 2025-12-31 | $14.14M | -9.7% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $6.58M | -48.4% |
| SkinHealth Systems Inc. (SKIN) | 2025-12-31 | $5.63M | -10.6% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $2.10M | -11.9% |
Compare SIBN, TMCI, HTFL, CERS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗